These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37980665)

  • 1. Effect of Virgin Coconut Oil Supplementation on Cognition of Individuals with Mild-to-Moderate Alzheimer's Disease in Sri Lanka (VCO-AD Study): A Randomized Placebo-Controlled Trial.
    Fernando MG; Silva R; Fernando WMADB; de Silva HA; Wickremasinghe AR; Dissanayake AS; Sohrabi HR; Martins RN; Williams SS
    J Alzheimers Dis; 2023; 96(3):1195-1206. PubMed ID: 37980665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of possible neuroprotective effects of virgin coconut oil on aluminum-induced neurotoxicity in an in vitro Alzheimer's disease model.
    Demirel G; Sanajou S; Yirün A; Çakir DA; Berkkan A; Baydar T; Erkekoğlu P
    J Appl Toxicol; 2024 Apr; 44(4):609-622. PubMed ID: 37989595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer's Disease.
    Jiang J; Hong Y; Li W; Wang A; Jiang S; Jiang T; Wang Y; Wang L; Yang S; Ren Q; Zou X; Xu J
    J Alzheimers Dis; 2023; 96(2):669-681. PubMed ID: 37840496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Cheng YC; Huang YC; Liu HC
    Dement Geriatr Cogn Disord; 2018; 45(5-6):335-352. PubMed ID: 30041236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible prophylactic anti-excitotoxic and anti-oxidant effects of virgin coconut oil on aluminium chloride-induced Alzheimer's in rat models.
    Alghamdi BSA
    J Integr Neurosci; 2018; 17(3-4):593-607. PubMed ID: 30010139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virgin coconut oil (VCO) supplementation relieves symptoms and inflammation among COVID-19 positive adults: a single-blind randomized trial.
    Angeles-Agdeppa I; Nacis JS; Dayrit FM; Tanda KV
    J Nutr Sci; 2024; 13():e5. PubMed ID: 38282651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal analysis of
    Fokuoh E; Xiao D; Fang W; Liu Y; Lu Y; Wang K
    J Genet; 2021; 100():. PubMed ID: 34470924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.
    Tomaszewski N; He X; Solomon V; Lee M; Mack WJ; Quinn JF; Braskie MN; Yassine HN
    J Alzheimers Dis; 2020; 74(3):975-990. PubMed ID: 32116250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4
    Xu Q; Zhang Y; Zhang X; Liu L; Zhou B; Mo R; Li Y; Li H; Li F; Tao Y; Liu Y; Xue C
    Clin Nutr; 2020 Jul; 39(7):2092-2105. PubMed ID: 31694759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of virgin coconut oil consumption on metabolic syndrome components and asymmetric dimethylarginine: A randomized controlled clinical trial.
    Nikooei P; Hosseinzadeh-Attar MJ; Asghari S; Norouzy A; Yaseri M; Vasheghani-Farahani A
    Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):939-949. PubMed ID: 33549429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
    J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary Supplementation with Virgin Coconut Oil Improves Lipid Profile and Hepatic Antioxidant Status and Has Potential Benefits on Cardiovascular Risk Indices in Normal Rats.
    Famurewa AC; Ekeleme-Egedigwe CA; Nwali SC; Agbo NN; Obi JN; Ezechukwu GC
    J Diet Suppl; 2018 May; 15(3):330-342. PubMed ID: 28816548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M; Grimley EJ; Areosa SA
    Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.
    Santoro A; Siviero P; Minicuci N; Bellavista E; Mishto M; Olivieri F; Marchegiani F; Chiamenti AM; Benussi L; Ghidoni R; Nacmias B; Bagnoli S; Ginestroni A; Scarpino O; Feraco E; Gianni W; Cruciani G; Paganelli R; Di Iorio A; Scognamiglio M; Grimaldi LM; Gabelli C; Sorbi S; Binetti G; Crepaldi G; Franceschi C
    CNS Drugs; 2010 Feb; 24(2):163-76. PubMed ID: 20088621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virgin coconut oil (VCO) by normalizing NLRP3 inflammasome showed potential neuroprotective effects in Amyloid-β induced toxicity and high-fat diet fed rat.
    Mirzaei F; Khazaei M; Komaki A; Amiri I; Jalili C
    Food Chem Toxicol; 2018 Aug; 118():68-83. PubMed ID: 29729307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease.
    Yassine HN; Rawat V; Mack WJ; Quinn JF; Yurko-Mauro K; Bailey-Hall E; Aisen PS; Chui HC; Schneider LS
    Alzheimers Res Ther; 2016 Jun; 8():25. PubMed ID: 27358067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial.
    Sparks DL; Connor DJ; Sabbagh MN; Petersen RB; Lopez J; Browne P
    Acta Neurol Scand Suppl; 2006; 185():3-7. PubMed ID: 16866904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.
    Khan W; Giampietro V; Banaschewski T; Barker GJ; Bokde AL; Büchel C; Conrod P; Flor H; Frouin V; Garavan H; Gowland P; Heinz A; Ittermann B; Lemaître H; Nees F; Paus T; Pausova Z; Rietschel M; Smolka MN; Ströhle A; Gallinat J; Vellas B; Soininen H; Kloszewska I; Tsolaki M; Mecocci P; Spenger C; Villemagne VL; Masters CL; Muehlboeck JS; Bäckman L; Fratiglioni L; Kalpouzos G; Wahlund LO; Schumann G; Lovestone S; Williams SC; Westman E; Simmons A; ; ;
    J Alzheimers Dis; 2017; 56(3):1159-1174. PubMed ID: 28157104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study.
    Torosyan N; Sethanandha C; Grill JD; Dilley ML; Lee J; Cummings JL; Ossinalde C; Silverman DH
    Exp Gerontol; 2018 Oct; 111():118-121. PubMed ID: 30006299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.